(Tromsø 07. September 2016) Børge Sørvoll, CFO of Biotec Pharmacon has purchased
4.503 shares at NOK 11.10 per share. After this transaction holds Børge
Sørvoll 5.652 shares and 82.500 options in Biotec Pharmacon
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.
For further information, please contact
Børge Sørvoll
CFO
+47 952 90 187
borge.sorvoll@biotec.no